FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to What are the risks and benefits of using BPC (Body Protection Compound) 157 supplements for therapeutic purposes? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide BPC 157 Does It Work? Breaking Down the Evidence and the Hype